Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

被引:50
|
作者
Choi, Hyun Sook [1 ,2 ]
Park, Mi Sook [1 ,2 ]
Kim, Seung Hwan [3 ]
Hwang, Bang Yeon [1 ,2 ]
Lee, Chong Kil [1 ,2 ]
Lee, Myung Koo [1 ,2 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Res Ctr Bioresource & Hlth, Cheongju 361763, South Korea
[3] Kyung Hee Univ, Coll Phys Educ, Yongin 449701, South Korea
来源
MOLECULES | 2010年 / 15卷 / 04期
关键词
Gynostemma pentaphyllum; 6-hydroxydopamine-lesioned rats; tyrosine hydroxylase; dopamine; Parkinson's disease; L-DOPA; CUCURBITACEAE PLANTS; SAPONIN CONSTITUENTS; BRAIN; 6-OHDA; CELLS; IRON;
D O I
10.3390/molecules15042814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6-Hydroxydopamine administration for 28 days (8 mu g/2 mu L) reduced the number of tyrosine hydroxylase (TH)-immunopositive neurons to 40.2% in the substantia nigra compared to the intact contralateral side. Dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine levels were reduced to 19.1%, 52.3%, 47.1% and 67.4% in the striatum of 6-hydroxydopamine-lesioned rats compared to the control group, respectively. However, an oral administration of herbal ethanol extracts from Gynostemma pentaphyllum (GP-EX) (10 mg/kg and 30 mg/kg) starting on day 3 post-lesion for 28 days markedly ameliorated the reduction of TH-immunopositive neurons induced by 6-hydroxydopamine-lesioned rat brain from 40.2% to 67.4% and 75.8% in the substantia nigra. GP-EX administration (10 and 30 mg/kg) also recovered the levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine in post-lesion striatum to 64.1% and 65.0%, 77.9% and 89.7%, 82.6% and 90.2%, and 88.1% and 89.2% of the control group. GP-EX at the given doses did not produce any sign of toxicity such as weight loss, diarrhea and vomiting in rats during the 28 day treatment period and four gypenoside derivatives, gynosaponin TN-1, gynosaponin TN-2, gypenoside XLV and gypenoside LXXIV were identified from GP-EX. These results suggest that GP-EX might be helpful in the prevention of Parkinson's disease.
引用
收藏
页码:2814 / 2824
页数:11
相关论文
共 50 条
  • [31] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    M. Mirzaie
    M. Khalili
    Z. Kiasalari
    M. Roghani
    Neurophysiology, 2016, 48 : 176 - 183
  • [32] The study of neuroprotective drugs in the striatal and the MFB 6-hydroxydopamine rat model for Parkinson's disease
    Mertens, B.
    Massie, A.
    Michotte, Y.
    Sarre, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 73 - 73
  • [33] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Mirzaie, M.
    Khalili, M.
    Kiasalari, Z.
    Roghani, M.
    NEUROPHYSIOLOGY, 2016, 48 (03) : 176 - 183
  • [34] Neuroprotective effect of pioglitazone in the 6-hydroxydopamine model of Parkinson's disease
    Machado, M. M. F.
    Bassani, T. B.
    Moura, E. L. R.
    Coppola-Segovia, V.
    Zanata, S.
    Vital, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S652 - S652
  • [35] The 6-hydroxydopamine Rat Model of Parkinson's Disease
    Guimaraes, Rayanne Poletti
    Ribeiro, Danilo Leandro
    dos Santos, Keila Bariotto
    Godoy, Livea Dornela
    Correa, Mirella Rosine
    Padovan-Neto, Fernando Eduardo
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (176):
  • [36] Long-term restorative effects of bromocriptine on operant responding in the 6-hydroxydopamine-lesioned rat
    Murphy, Ellen M.
    Lelos, Mariah J.
    O'Neill, Michael J.
    Lane, Emma L.
    Dunnett, Stephen B.
    NEUROREPORT, 2013, 24 (18) : 1019 - 1024
  • [37] Entacapone increases and prolongs the central effects of L-DOPA in the 6-hydroxydopamine-lesioned rat
    Gerlach, M
    van den Buuse, M
    Blaha, C
    Bremen, D
    Riederer, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (05) : 388 - 394
  • [38] Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat
    Manfred Gerlach
    Maarten van den Buuse
    Charles Blaha
    Dirk Bremen
    Peter Riederer
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 370 : 388 - 394
  • [39] Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson’s disease
    Laurence Mignon
    William A. Wolf
    Psychopharmacology, 2007, 192 : 49 - 59
  • [40] Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat:: implications for treating Parkinson's disease
    Mignon, Laurence
    Wolf, William A.
    PSYCHOPHARMACOLOGY, 2007, 192 (01) : 49 - 59